Literature DB >> 24445980

Comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure.

Punkaj Gupta1, Jerril W Green2, Xinyu Tang3, Christine M Gall4, Jeffrey M Gossett3, Tom B Rice5, Robert M Kacmarek6, Randall C Wetzel7.   

Abstract

IMPORTANCE: Outcomes associated with use of high-frequency oscillatory ventilation (HFOV) in children with acute respiratory failure have not been established.
OBJECTIVE: To compare the outcomes of HFOV with those of conventional mechanical ventilation (CMV) in children with acute respiratory failure. DESIGN, SETTING, AND PARTICIPANTS: We performed a retrospective, observational study using deidentified data obtained from all consecutive patients receiving mechanical ventilation aged 1 month to 18 years in the Virtual PICU System database from January 1, 2009, through December 31, 2011. The study population was divided into 2 groups: HFOV and CMV. The HFOV group was further divided into early and late HFOV. Propensity score matching was performed as a 1-to-1 match of HFOV and CMV patients. A similar matching process was performed for early HFOV and CMV patients. EXPOSURE: High-frequency oscillatory ventilation. MAIN OUTCOMES AND MEASURES: Length of mechanical ventilation, intensive care unit (ICU) length of stay, ICU mortality, and standardized mortality ratio (SMR).
RESULTS: A total of 9177 patients from 98 hospitals qualified for inclusion. Of these, 902 (9.8%) received HFOV, whereas 8275 (90.2%) received CMV. A total of 1764 patients were matched to compare HFOV and CMV, whereas 942 patients were matched to compare early HFOV and CMV. Length of mechanical ventilation (CMV vs HFOV: 14.6 vs 20.3 days, P < .001; CMV vs early HFOV: 14.6 vs 15.9 days, P < .001), ICU length of stay (19.1 vs 24.9 days, P < .001; 19.3 vs 19.5 days, P = .03), and mortality (8.4% vs 17.3%, P < .001; 8.3% vs 18.1%, P < .001) were significantly higher in HFOV and early HFOV patients compared with CMV patients. The SMR in the HFOV group was 2.00 (95% CI, 1.71-2.35) compared with an SMR in the CMV group of 0.85 (95% CI, 0.68-1.07). The SMR in the early HFOV group was 1.62 (95% CI, 1.31-2.01) compared with an SMR in the CMV group of 0.76 (95% CI, 0.62-1.16). CONCLUSIONS AND RELEVANCE: Application of HFOV and early HFOV compared with CMV in children with acute respiratory failure is associated with worse outcomes. The results of our study are similar to recently published studies in adults comparing these 2 modalities of ventilation for acute respiratory distress syndrome.

Entities:  

Mesh:

Year:  2014        PMID: 24445980     DOI: 10.1001/jamapediatrics.2013.4463

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  24 in total

Review 1.  Did studies on HFOV fail to improve ARDS survival because they did not decrease VILI? On the potential validity of a physiological concept enounced several decades ago.

Authors:  Didier Dreyfuss; Jean-Damien Ricard; Stéphane Gaudry
Journal:  Intensive Care Med       Date:  2015-10-05       Impact factor: 17.440

2.  Multiple Organ Dysfunction in Children Mechanically Ventilated for Acute Respiratory Failure.

Authors:  Scott L Weiss; Lisa A Asaro; Heidi R Flori; Geoffrey L Allen; David Wypij; Martha A Q Curley
Journal:  Pediatr Crit Care Med       Date:  2017-04       Impact factor: 3.624

3.  The top ten unknowns in paediatric mechanical ventilation.

Authors:  Peter C Rimensberger; Ira M Cheifetz; Martin C J Kneyber
Journal:  Intensive Care Med       Date:  2017-05-29       Impact factor: 17.440

4.  Early Use of Adjunctive Therapies for Pediatric Acute Respiratory Distress Syndrome: A PARDIE Study.

Authors:  Courtney M Rowan; Margaret J Klein; Deyin Doreen Hsing; Mary K Dahmer; Philip C Spinella; Guillaume Emeriaud; Amanda B Hassinger; Byron E Piñeres-Olave; Heidi R Flori; Bereketeab Haileselassie; Yolanda M Lopez-Fernandez; Ranjit S Chima; Steven L Shein; Aline B Maddux; Jon Lillie; Ledys Izquierdo; Martin C J Kneyber; Lincoln S Smith; Robinder G Khemani; Neal J Thomas; Nadir Yehya
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

5.  Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit.

Authors:  Matt S Zinter; Steven G DuBois; Aaron Spicer; Katherine Matthay; Anil Sapru
Journal:  Intensive Care Med       Date:  2014-07-15       Impact factor: 17.440

6.  How to manage ventilation in pediatric acute respiratory distress syndrome?

Authors:  Martin C J Kneyber; Philippe A Jouvet; Peter C Rimensberger
Journal:  Intensive Care Med       Date:  2014-09-20       Impact factor: 17.440

7.  High-Frequency Oscillatory Ventilation Use and Severe Pediatric ARDS in the Pediatric Hematopoietic Cell Transplant Recipient.

Authors:  Courtney M Rowan; Ashley Loomis; Jennifer McArthur; Lincoln S Smith; Shira J Gertz; Julie C Fitzgerald; Mara E Nitu; Elizabeth As Moser; Deyin D Hsing; Christine N Duncan; Kris M Mahadeo; Jerelyn Moffet; Mark W Hall; Emily L Pinos; Robert F Tamburro; Ira M Cheifetz
Journal:  Respir Care       Date:  2017-12-26       Impact factor: 2.258

Review 8.  Ventilator-induced lung injury in children: a reality?

Authors:  Alette A Koopman; Pauline de Jager; Robert G T Blokpoel; Martin C J Kneyber
Journal:  Ann Transl Med       Date:  2019-10

9.  Early High-Frequency Oscillatory Ventilation in Pediatric Acute Respiratory Failure. A Propensity Score Analysis.

Authors:  Scot T Bateman; Santiago Borasino; Lisa A Asaro; Ira M Cheifetz; Shelley Diane; David Wypij; Martha A Q Curley
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

10.  Variability in Usual Care Mechanical Ventilation for Pediatric Acute Respiratory Distress Syndrome: Time for a Decision Support Protocol?

Authors:  Christopher J L Newth; Katherine A Sward; Robinder G Khemani; Kent Page; Kathleen L Meert; Joseph A Carcillo; Thomas P Shanley; Frank W Moler; Murray M Pollack; Heidi J Dalton; David L Wessel; John T Berger; Robert A Berg; Rick E Harrison; Richard Holubkov; Allan Doctor; J Michael Dean; Tammara L Jenkins; Carol E Nicholson
Journal:  Pediatr Crit Care Med       Date:  2017-11       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.